An Ebola whole virus vaccine, constructed using a novel experimental platform, has been shown to effectively protect monkeys exposed to the often fatal virus.

Five University of Guelph discoveries are being recognized as life-changing breakthroughs by the Council of Ontario Universities (COU).

Study finds vaccination rate far below what’s needed to keep virus in check.

Johns Hopkins computer scientist part of team looking at why people refuse vaccines and how these reasons vary among communities.

Linsey Marr, a professor in the Charles E. Via Jr. Department of Civil and Environmental Engineering at Virginia Tech, is obsessed with flu transmission.

Stanford University announced Jan. 29 that it has received a grant from the Bill & Melinda Gates Foundation to accelerate efforts in vaccine development. The $50 million grant over 10 years will build on existing technology developed at Stanford and housed in the Human Immune Monitoring Core, and will establish the Stanford Human Systems Immunology Center. The center aims to better understand how the immune system can be harnessed to develop vaccines for the world's most deadly infectious diseases.

New research from the Journal of Medicinal Chemistry may help millions stick to a common resolution: quitting smoking

Study indicates target for future drugs for measles, Ebola, RSV.

The new transport system for DNA vaccines could help treat HIV, malaria, HPV and other major illnesses.

What do pacemakers, prosthetic limbs, Iron Man and flu vaccines all have in common?